Proteomics. Clinical Applications, 1862-8346
Journal
- 2019
- Hoff, F. W., Hu, C. W., Qutub, A. A., Qiu, Y., Hornbaker, M. J., Bueso-Ramos, C., Abbas, H. A., Post, S. M., de Bont, E. S. J. M., & Kornblau, S. M. (2019). Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse. Proteomics. Clinical Applications, 13(4), [1800133]. https://doi.org/10.1002/prca.201800133
- Zeneyedpour, L., Dekker, L. J. M., van Sten-van't Hoff, J. J. M., Burgers, P. C., ten Hacken, N. H. T., & Luider, T. M. (2019). Neoantigens in Chronic Obstructive Pulmonary Disease and Lung Cancer: A Point of View. Proteomics. Clinical Applications, 13(2), [1800093]. https://doi.org/10.1002/prca.201800093
- 2018
- Güzel, C., Govorukhina, N. I., Stingl, C., Dekker, L. J. M., Boichenko, A., van der Zee, A. G. J., Bischoff, R., & Luidert, T. M. (2018). Comparison of Targeted Mass Spectrometry Techniques With an Immunoassay: A Case Study For HSP90α. Proteomics. Clinical Applications, 12(1), [1700107]. https://doi.org/10.1002/prca.201700107
- 2014
- Ljunggren, S., Levels, J. H. M., Turkina, M. V., Sundberg, S., Bochem, A. E., Hovingh, K., Holleboom, A. G., Lindahl, M., Kuivenhoven, J. A., & Karlsson, H. (2014). ApoA-I mutations, L202P and K131del, in HDL from heterozygotes with low HDL-C. Proteomics. Clinical Applications, 8(3-4), 241-250. https://doi.org/10.1002/prca.201300014
- 2007
- Jimenez, C. R., El Filali, Z., Knol, J. C., Hoekman, K., Kruyt, F. A. E., Giaccone, G., Smit, A. B., & Li, K. W. (2007). Automated-serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS. Proteomics. Clinical Applications, 1(6), 598-604. https://doi.org/10.1002/prca.200600483
ID: 13948966